Boston, MA -- (SBWIRE) -- 07/26/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: Affymax, Inc. (OTCMKTS:APPA), Telecom Corp of New Zealand (ADR) (OTCMKTS:NZTCY), Arch Therapeutics Inc (OTCBB:ARTH), Liquidmetal Technologies Inc (OTCBB:LQMT)
Affymax, Inc. (OTCMKTS:APPA) was a volume gainer of 2.00 million shares and the average volume of the stock remained 757,278 shares. The stock opened the session at $1.18 and finished at the end of the day at $1.33and the stock escalated 13.68%.The market capitalization of the stock remained 49.86 million. The half-yearly trend of the stock remained negative -93.2%. Affymax, Inc., a biopharmaceutical company, engages in discovering, developing, and delivering therapies that improve the lives of patients with kidney diseases, and other serious and life-threatening illnesses. It offers OMONTYS (peginesatide) injection for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. OMONTYS is a synthetic peptide-based erythropoiesis stimulating agent designed to stimulate production of red blood cells.
What was the Moving Force behind APPA on Bullish Run? Read This Research Report
In the preceding trading session, Telecom Corp of New Zealand (ADR) (OTCMKTS:NZTCY) exchanged 270,023 shares and the average volume remained 129,239shares. The stock closed the session at $9.25 with the gain of 0.86%. Tracking three months and 6 months trends, the stock was at of -15.08% and -2.81%, respectively. Telecom Corporation of New Zealand Limited, together with its subsidiaries, provides telecommunications services, information technology (IT) services, and network services in New Zealand and Australia.
For How Long NZTCY will fight for Profitability? Read This Trend Analysis report
Arch Therapeutics Inc (OTCBB:ARTH)enhanced 21.43% and its closing price was $0.680. The volume of the stock was 3.09 million shares and the average volume remained 1.85 million shares. Yesterday, the stock traded amid the day price range of $0.59 - $0.69. The market capitalization of the stock remained 29.92 million. Arch Therapeutics, Inc. (ARTH) a life science company and developer of AC5™, a novel product aimed at controlling bleeding and fluid loss in order to provide faster and safer surgical and interventional care, is pleased to advise that co-founding and inventing scientist, Dr. Rutledge Ellis-Behnke, delivered a lecture titled "The Spider Effect, how the Immune System in the Brain can be Measured and Modulated with Nanotechnology" at the 6th annual European Foundation for Clinical Nanomedicine (CLINAM) Summit in Basel, Switzerland.
For How Long ARTH Gloss will Attract Investors? Find out via this report
Liquidmetal Technologies Inc (OTCBB:LQMT) exchanged 10.11 million shares in the previous trading session, and its average trading remained 13.35 million shares. LQMT advanced 2.92% and it closed the trading at $0.180. The market capitalization of the stock remained 46.07 million. YTD trend of the stock was positive 71.43%. Liquidmetal Technologies, Inc., a materials technology company, designs, develops, and sells products and components from bulk amorphous alloys worldwide. The company offers components for non-consumer electronic devices, including parts for high end printers, commercial imaging devices, aerospace and defense components, medical devices, automotive components, and industrial machines.
Will LQMT Continue To Move Higher? Find Out Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)